ANI Pharmaceuticals, Inc.ANIPNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Over Time
Trending higher, above historical average, strong compound growth.
Left:
||||
Revenue minus cost of goods sold
Latest
$364.17M
↑ 128% above average
Average (9y)
$159.71M
Historical baseline
Range
High:$364.17M
Low:$63.63M
CAGR
+21.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $364.17M | +19.3% |
| 2023 | $305.30M | +71.9% |
| 2022 | $177.60M | +53.7% |
| 2021 | $115.53M | -4.8% |
| 2020 | $121.32M | -15.4% |
| 2019 | $143.39M | +11.5% |
| 2018 | $128.55M | +31.4% |
| 2017 | $97.81M | +22.5% |
| 2016 | $79.84M | +25.5% |
| 2015 | $63.63M | - |